Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Evidence-Based Truth About AHK-Cu Dosage Protocols Here's the honest answer: most AHK-Cu protocols fail because researchers treat it like a stable small-molecule drug when it's actually a fragile metal-coordinated peptide that degrades the moment storage or handling deviates from spec
Hoff et al., 2024) (Fig
Most animals are able to synthesize their own vitamin C
None of these therapeutic interventions reliably halt or reverse the underlying neurodegenerative progression in PD
Unapproved products are risky not only because they havent been reviewed by the FDA, but because theres no way to know their potency, possible contamination, or potential dosing errors
Ristoff E, Mayatepek E, Larsson A: Long-term clinical outcome in patients with glutathione synthetase deficiency
